New social media post that was published on Yahoo! in 2013:
Effective use of social media — such as Facebook, LinkedIn, YouTube,
Google+ and Twitter – in your business is essential to maximizing your
online sales. Effective social media marketing programs are focused on
creating interesting content that encourages readers to share the
information with their social networks.
Why should you worry about social networking in your business?
Because a corporate marketing message that comes from people you know is
much more likely for you to buy into. And, you are much more likely to
spread that message to your social network if the message came from a
The Case of Ford Motor Company
There is no better example of the power of social media to revitalize a brand than Ford Motor Company.
Ford was hurting big time following the recession that started in 2008,
with a major drop in its share price. However, Ford has shown to be
very resilient, as it rejected TARP bailouts and truly embraced the
power of social media to boost sales.
Ford currently has at least 80 Facebook pages, with more than 14.7
million fans, that they use for various marketing campaigns. Their
global head of social media, Scott Monty, gets that people interested in Ford products want to see a lot of diverse and interesting content. That is why the company is constantly tweaking its marketing messages in social media. Ford was recently ranked #9 by OnlineMBAPage.com in a recently published list of the Top 50 Most Social Media Friendly Fortune 500 Companies for 2013.
Ford was one of the first companies to sign up on Google+, and it has
emerged as one of the corporate powers of the social media world. Ford
has been able to restore its brand to some level of prominence because
of its effectiveness in directly connecting with customers on social
Check out some of the social media statistics for Ford today:
- Facebook: 80 pages, 1,763,000 likes and 14.7 million fans
- Twitter: 186,000 followers
- YouTube: 109,000 subscribers
- LinkedIn: 155,000 followers
- Google+: Circled by 1,900,000
Ford has put together some very successful social media campaigns. Some examples:
- Fiesta Movement: Ford gave Fiestas to 100 young people and let them drive the cars for six months, posting videos and blogging about the experiences.
- Random Acts of Fusion: This campaign started with a teaser video on the Fusion Facebook page, where Ryan Seacrest urged Ford fans to work together to unlock more content by giving 1,000 likes on the Facebook page. The goal was reached in 24 hours.
- How to Focus Your Car: This cool campaign was created to show off the Focus as a high-tech vehicle that young drivers should enjoy driving.
- Doug, Ford’s Spokespuppet: Ford did a campaign with a puppet as a spokesperson. It encouraged Ford fans to go to Doug’s Facebook page and like it. The goal was 10,000 – it got 43,000 likes in 2011.
Ford’s great success with social media marketing is a great indicator
of what can be done in the social media space by progressive companies.
Ford is not the only large corporation to hit the target on social
media campaigns. Other big social media campaign successes have
#1 Oreo – You Can Still Dunk in the Dark
This brilliant social media campaign was cooked up on the fly during
the 2013 Superbowl by the advertising company Mondelez International.
These guys had no idea that the power would go out in the Superbowl, but
they had a team watching the game, ready to launch a social media
campaign on the spot.
Their Oreo advertisement, cooked up in minutes when the lights dimmed in the Superdome during the game, was released on Twitter and was retweeted 15,000 times in 14 hours.
#2 Mello Yello – They Call Me Mello Yello
If you grew up in the 1980s, you probably remember the citrusy soda
Mello Yello. It is still around, but many people were not very familiar
with it anymore. Mello Yello recently came up with a new social media campaign
that played off of the 1966 hit song by Donovan. Mello Yello
aggressively used Facebook to spread the new message to old fans of the
product, and also thousands of Millennials who weren’t around in the
Mello Yello also launched a Facebook page
, which included a cool Retro Smooth Photo Generator. It allows users
to take a photo of themselves and go from ‘not smooth’ to ‘smooth,’ by
using a hipster-style photo filter.
#3 Grey Poupon – The Society of Good Taste
It is a rare social media campaign that requires you to fill out an
application to become a Facebook fan of the product. But that is exactly
what Grey Poupon did in 2012.
The idea behind this unusual campaign was to create a sense of exclusivity for the Facebook page for Grey Poupon mustard. It also attempted to develop a highly relevant and qualified Facebook audience.
Users who wanted to become fans – get this – had to APPLY to become
members through the Society of Good Taste application! The app scanned
your profile in Facebook and learned about your friends and interests.
Then it assigned you a score to determine if your taste was good enough
to become a fan of Grey Poupon.
This very unusual campaign was highly successful in building brand awareness for Grey Poupon.
#4 Sephora – 15 Days of Beauty Thrills
The goal of this Facebook campaign in
2012 was to attract fans and to drive more traffic to the new Sephora
website. Sephora utilized some of its beauty partners, such as Urban
Decay, Pantone Universe, Make Up For Ever and others, to provide
‘thrills’ for the Sephora Facebook community. Some of these thrills
included a $5000 shopping spree, a new Fiat, a trip to Paris and several
Sephora also used a fan-gated application that required you to like
the Sephora Facebook page to gain access. Fans learned about new thrills
at midnight the day before, and they could enter to win the thrill each
day on Sephora.com
This Facebook media campaign worked because it created a strong sense
of exclusivity. It offered insights and special, thrilling deals to its
Facebook fans that they could not get elsewhere.
All of these companies are really leveraging the power of social
media to drive their sales and brand awareness to the next level.
Sample Oct. 2011 for a real estate site:
Why Shouldn’t I Contact the Listing Agent?
The last thing you want to do as an Athens, Ga home buyer is to call the agent on that home listing.
Listing Agents Represent the Seller, Not You, The Buyer.
The seller’s agent has a contractual agreement with the seller to achieve the best possible results for the seller. That’s right. The seller's agent will be very friendly and seemingly helpful, but, make no mistake and do not be fooled, that agent has a legal and fiduciary responsibility to the seller- not you.
You can easily end up paying thousands of dollars more for your home by dealing with a seller’s agent.
Why You Need A Buyer’s Agent
Every buyer should be represented by a buyer’s agent. A buyer’s agent is your advocate to ensure you get the best property at the lowest price.
Our site features the complete MLS listings for the Athens, Ga area. So you can find that perfect home. But, when you need an agent, that’s where we come in. We are here to help you before you accidently get stuck with a real estate agent who does not represent your interests. We can help you find the right real estate professional along with other local professionals like builders, inspectors, mortgagers, insurers, surveyors and attorneys.
What About Commissions?
The seller always pays the real estate commissions in a real estate transaction. Any commission your buyer’s agent receives comes from the seller, not from you.
We are experienced brokers, developers and builders with decades of experience and 1000's of transactions. Through a conversation we will get to know your situation, needs and personality. Then we'll connect you with a buyer’s agent that best fits your needs in your search for your Athens Home.
There is no obligation when you search on our site or talk to us on the phone. We simply want to provide you the best possible advice and get you the best representation as a buyer.
Get in touch with us today!
This is a sample I wrote Sept. 14 for e-firstaidsupplies. com:
Why You Should Choose Us As Your Medical Glove Supplier
Medical examination gloves protect both medical professionals and patients from dangerous blood borne pathogens. These items are a disposable item, so they can be a major routine expense for many medical practitioners. That is why it is becoming more common for many hospitals to use only one type of glove, or even one size to cut costs.
At e-firstaidsupply.com, we do not recommend this practice. We provide you with the most complete stock of glove materials and sizes to best suit your patients’ needs. Our glove line gives you the ultimate in:
· Materials. All medical gloves provide protection, but the type of material they are made of makes a difference. A primary care facility, intensive care ward, and emergency room do not have the same needs, so the type of glove for each will vary. We give you a full choice of the best latex, vinyl, and nitrile for your environment. Whether you need a thicker nirile glove of 6 mm thickness for your ER, or a 4 mm latex for your regular ward, we have your needs covered here.
· Sizes. One of the most common ways to cut costs is to have only one size for an entire facility. This is not recommended, because a poor fitting glove is a glove that some people will decide to avoid. Also, if the glove is too small, some professionals will tear them off, thereby increasing your expenses. This will not be a problem, because we provide a full line of medical gloves in all the common sizes for men and women.
· Price. By using our complete line of products, you will have everything you need for every department in your facility. But your costs will be kept low, because our prices are the most competitive in the industry.
Learn more about our wide line of latex, vinyl and nitrile gloves here.
Here are sample pharmaceutical articles I wrote this year:
U.S. to have 3 drug inspectors in China by end of year; Chinese authorities disagree
FDA continues to work toward establishing eight full-time, permanent positions at U.S. diplomatic posts in China, according to an import safety action plan update released July 2.
Also, HHS Secretary Michael Leavitt stated that he expects FDA will have investigators in three Chinese cities by the end of 2008.
However, Li Changjiang, head of the Chinese agency that oversees quality control, disagreed last month, saying that the issue had not been totally resolved because U.S. authorities have not granted permission to permit Chinese food and drug inspectors in the U.S.
According to published reports, Li said: “The relevant U.S. authorities are still following through and we have yet to receive the go-ahead” for the Chinese inspectors in the United States.
Entitled the “Import Safety – Action Plan Update,” the just-released report outlines steps taken by the federal government, private sector and international partners to bolster import safety. Since November 2007, there have been strong enforcement actions, signed agreements with key trading partners, bilateral and multilateral discussions, critical information sharing on safety and best practices, and a process begun to improve safety practices both inside and outside of government, FDA stated.
According to the report, FDA is working with New Mexico State University to develop a prototype system for improving electronic screening, using open-source intelligence, of imported products offered for entry into the U.S. The evaluation of the prototype system PREDICT (Predictive Risk-Based Evaluation of Dynamic Import Compliance Targeting) has been completed and the final pilot evaluation document is under review.
Further, the report stated that the Department of Homeland Security’s Customs and Border Protection (CBP) Agency is coordinating to ensure harmonized government procedures and requirements in importation. CBP is working toward a shared automated system permitting information gathering and sharing among participating import safety agencies.
The agency stated in the import update that it continues to work with the Chinese government to improve testing for drug contamination to prevent cases such as heparin, which led to at least 80 deaths in the U.S. The report stated that working with the Chinese government “was more efficient due to two previous Memoranda of Agreement that were put in place last December to enhance the safety of a wide variety of food, feed, drugs and medical devices traded between the two nations.”
Also, the U.S. government participated in a forum with Central American countries to discuss ways to ensure the safety of manufactured goods and foods as they move between countries. Similar discussions have occurred with the leaders of other countries, including China, Vietnam and India.
In addition, FDA July 2 released an update on the Food Protection Plan (FPP), which addresses safety and food defense for domestic and imported products, some of which applies to drugs and medical devices.
The FPP stated that the implementation of the China Memorandum of Agreement (MOA) has begun. FDA has met its first set of deadlines by providing registration materials to the Chinese government, identifying points of contact for the MOA and drafting the first five-year work plan.
An FDA delegation visited Indian counterparts to discuss requirements for an FDA presence in India. Results are promising for future collaboration.
In April, the FDA Commissioner traveled to Jordan to explore the possibilities of enhanced collaboration between FDA and Jordan.
The report noted that FDA is exploring an FDA presence in Latin America/Central America.
“FDA is working to enhance traceability capabilities because the ability to quickly identify where a contaminated product came from and where it has been distributed is essential for a rapid response,” the report added.
Also, FDA currently is engaging in dialogue with industry and other stakeholders on current traceability models and standards to identify best practices for traceability.
Questions remain about policies and membership of drug safety board
ROCKVILLE, MD – As FDA’s newly-formed and independent Drug Safety Oversight Board (DSB) continues to take shape, a number of unanswered questions remain, such as, what will the criteria be for determining what is an emerging drug issue, and what will be the policy by which drugs are put on and taken off the Drug Watch List?
At a meeting of the FDA Science Board Advisory Committee here April 15 on pre- and post-marketing drug safety programs, numerous stakeholders asked tough questions about the DSB, which was announced by HHS Secretary Michael Levitt in February.
For example, several panelists grilled Galson about the Drug Watch List, a new section on the FDA website that will contain emerging data and information about drugs to increase transparency and public knowledge of drug safety issues.
“There will be a policy where a drug can go on and off watch,” responded Steven Galson, M.D., acting director, Center for Drugs. “As a communication tool, the list isn’t effective if it just grows and grows. The board will have to set criteria for taking them off, as well as on,”
According to an FDA press release, the DSB will “enhance the independence of internal deliberations and decisions regarding risk/ benefit analyses and consumer safety.” The Washington Post reported that the board would, for the first time, take the officials who approve new drugs largely out of the process of assessing whether side effects that appear later are serious enough to require quick regulatory action. The DSB will comprise FDA members and other government agencies and people from industry. One of its first initiatives will be to commission an Institute of Medicine study to look at drug safety from top to bottom.
But questions still came up at the advisory committee meeting if the new board is still too populated with people who approved the drugs in the first place. For example, one panelist asked: “Should there be a way to get a more distant oversight of this process, given all the internal people on the board? We need a mechanism to ensure there is an oversight so that it does not have anything to do with approving a drug.”
Galson responded: “I think that is an important concept. We are just in the early process of putting the board together, and we will examine all of the options.”
Acting Deputy Commissioner for Operations Janet Woodcock, M.D., noted: “Nothing we are doing in setting up this board is meant to diminish the role of advisory committees. It is not meant to supplant the efforts of our experts on the outside.”
Galson added that consumer groups would be represented on the Drug Safety Oversight Board. “They will represent all of the patient groups, and they will all have gone through the SJE Process and been vetted.”
Sen. Michael Enzi, (R-WY), speaking at a Food & Drug Law Institute (FDLI) meeting in Washington, D.C., April 7, said he is fighting the concept of a separate drug safety board. “When all you have is a hammer, you think everything is a nail. If I was on that new drug safety board and I saw some of the prescription drug commercials on TV with all the listed side effects, I’d pull every drug with that side effect.”
Enzi further commented that it is easy to overreact to adverse events, given all of the media exposure they receive. ““Every time we take a drug we take a risk, so we shouldn’t overreact. Pharma needs to do better job of promoting the miracles they have created. We don’t emphasize the miracles the industry is doing today. A drug that is unavailable is safe, but not effective.”